Report cover image

Specific Proteins Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Publisher GlobalData
Published Oct 27, 2022
Length 82 Pages
SKU # GBDT17531741

Description

Specific Proteins Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Summary

GlobalData's Medical Devices sector report, “Specific Proteins Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Specific Proteins pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Specific Proteins are reagents and test kits which are used to quantify and detect protein molecules from bodily fluids.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Specific Proteins under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Specific Proteins and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Specific Proteins under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

82 Pages
  • About GlobalData
    • Specific Proteins Overview
    • Specific Proteins - Pipeline Products by Stage of Development
    • Specific Proteins - Pipeline Products by Territory
    • Specific Proteins - Pipeline Products by Regulatory Path
    • Specific Proteins - Pipeline Products by Estimated Approval Date
    • Specific Proteins - Ongoing Clinical Trials
    • Specific Proteins Companies - Pipeline Products by Stage of Development
    • Specific Proteins – Companies Pipeline Products by Stage of Development
    • Alfa Wassermann Diagnostic Technologies, LLC Company Overview
    • Amerimmune LLC Company Overview
    • Beckman Coulter Inc Company Overview
    • China Medical Technologies Inc (Inactive) Company Overview
    • Colorado State University Company Overview
    • Fujirebio Diagnostics Inc Company Overview
    • Genesis Detection Systems, Inc. Company Overview
    • Guanine Inc Company Overview
    • Hologic Inc Company Overview
    • Isoformix Inc Company Overview
    • Numares AG Company Overview
    • Ortho Clinical Diagnostics Holdings Plc Company Overview
    • Ottawa Hospital Research Institute Company Overview
    • Roche Diagnostics International Ltd Company Overview
    • Sebia SA Company Overview
    • Siemens Healthcare Diagnostics Inc Company Overview
    • SomaLogic Inc Company Overview
    • Umea University Company Overview
    • University of California Company Overview
    • Oct 05, 2022: DiaSorin Gets $31M BARDA Funding for Point-of-Care Instrument
    • Aug 19, 2022: Bio-Works Sweden announce first half Jan – Jun 2022 results
    • Aug 01, 2022: PerkinElmer Announces Financial Results for the Second Quarter of 2022
    • Jul 25, 2022: Beckman Coulter partners with Mass General and BARDA to identify severe pediatric infections in emergency departments
    • Jul 20, 2022: Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance
    • May 04, 2022: Ortho Clinical Diagnostics Reports First Quarter 2022 Results
    • May 03, 2022: PerkinElmer Announces Financial Results for the First Quarter of 2022
    • Apr 26, 2022: Study of more than 18,000 patients finds exome sequencing delivers higher diagnostic rates for autism spectrum disorders
    • Apr 20, 2022: Ortho Clinical Diagnostics to Report First Quarter 2022 Results on May 4, 2022
    • Apr 12, 2022: BIO-TECHNE and Cygnus Technologies, part of Maravai LifeSciences, introduce new simple plex HEK 293 HCP 3G immunoassay
    • Apr 11, 2022: Aviva Systems Biology Launches AvivaBlot ECL Reagents for Western Blot
    • Apr 11, 2022: Aviva Systems Biology announces the launch of high throughput antibody characterization services
    • Mar 28, 2022: New order of WorkBeads - the next generation of protein purification - to Spanish CDMO 3P Biopharmaceuticals
    • Mar 18, 2022: Researchers study how gene expression changes in the brain in Alzheimer's disease
    • Mar 16, 2022: GeneDx announces discovery of 200 new and expanded genetic conditions
    • Mar 02, 2022: Opthea Expands Leadership Team with the Appointment of Joel Naor, M.D., M.Sc., MBA as Chief Medical Officer
    • Feb 16, 2022: Ortho Clinical Diagnostics Reports Fourth Quarter and Fiscal Year 2021 Results
    • Feb 10, 2022: PerkinElmer to Present at Citi’s 2022 Virtual Healthcare Conference
    • Feb 01, 2022: PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2021
    • Jan 06, 2022: SomaLogic partners with Illumina to develop proteomic solutions
    • Jan 03, 2022: Ortho Clinical Diagnostics to Participate in the 40th Annual JP Morgan Healthcare Conference
    • Jan 02, 2022: Ortho Clinical Diagnostics Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2021
    • Nov 16, 2021: PerkinElmer to Present at Evercore ISI HealthCONx Conference 2021
    • Nov 16, 2021: Artificial intelligence successfully predicts protein interactions
    • Oct 26, 2021: Bionova Scientific unveils new commercial-ready GMP biologics manufacturing facility at grand opening event
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us